Status:
ACTIVE_NOT_RECRUITING
Peri-conceptional or Pregnancy Exposure of Vaccination and the Risk of Adverse Pregnancy Outcomes
Lead Sponsor:
Sun Xin
Conditions:
Vaccine Adverse Reaction
Eligibility:
FEMALE
14-65 years
Brief Summary
Uing data from a population based cohort in China, we will conduct retrospective cohort study to evaluate the risk of vaccine (e.g., HPV/influenza/rabies vaccine) administered during pregnancy (especi...
Detailed Description
We will develop a vaccination cohort by linking population-based pregnancy registries (i.e., REPRESENT) with population-based vaccine databases. The researchers will use data from this cohort to exam...
Eligibility Criteria
Inclusion
- All pregnant women in Xiamen who registry in our database.
Exclusion
- Pregnant women who were lost to follow-up. Pregnant women exposed to related factors of known congenital malformation.
Key Trial Info
Start Date :
January 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 30 2025
Estimated Enrollment :
150000 Patients enrolled
Trial Details
Trial ID
NCT06180447
Start Date
January 1 2024
End Date
March 30 2025
Last Update
May 7 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The West China Hospital of Sichuan university
Chengdu, Sichuan, China, 610041